Snapshot
The global Myocardial Ischemia Drugs market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Myocardial Ischemia Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
BAY-606583
CMK-103
DT-010
Humanin
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Baxalta Incorporated
Bayer AG
Cellmid Limited
CohBar, Inc.
Lixte Biotechnology Holdings, Inc.
NoNO, Inc.
Symic Biomedical, Inc.
Taxus Cardium Pharmaceuticals Group Inc.
ViroMed Co., Ltd.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Clinic
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Content

1 Industry Overview
1.1 Myocardial Ischemia Drugs Industry
Figure Myocardial Ischemia Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Myocardial Ischemia Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Myocardial Ischemia Drugs
1.2.2 Downstream
Table Application Segment of Myocardial Ischemia Drugs
Table Global Myocardial Ischemia Drugs Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Myocardial Ischemia Drugs Market by Type
3.1 By Type
3.1.1 BAY-606583
Table Major Company List of BAY-606583
3.1.2 CMK-103
Table Major Company List of CMK-103
3.1.3 DT-010
Table Major Company List of DT-010
3.1.4 Humanin
Table Major Company List of Humanin
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Myocardial Ischemia Drugs Market 2015-2019, by Type, in USD Million
Figure Global Myocardial Ischemia Drugs Market Growth 2015-2019, by Type, in USD Million
Table Global Myocardial Ischemia Drugs Market 2015-2019, by Type, in Volume
Figure Global Myocardial Ischemia Drugs Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Myocardial Ischemia Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Myocardial Ischemia Drugs Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Baxalta Incorporated (Company Profile, Sales Data etc.)
4.1.1 Baxalta Incorporated Profile
Table Baxalta Incorporated Overview List
4.1.2 Baxalta Incorporated Products & Services
4.1.3 Baxalta Incorporated Business Operation Conditions
Table Business Operation of Baxalta Incorporated (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Bayer AG (Company Profile, Sales Data etc.)
4.2.1 Bayer AG Profile
Table Bayer AG Overview List
4.2.2 Bayer AG Products & Services
4.2.3 Bayer AG Business Operation Conditions
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Cellmid Limited (Company Profile, Sales Data etc.)
4.3.1 Cellmid Limited Profile
Table Cellmid Limited Overview List
4.3.2 Cellmid Limited Products & Services
4.3.3 Cellmid Limited Business Operation Conditions
Table Business Operation of Cellmid Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 CohBar, Inc. (Company Profile, Sales Data etc.)
4.4.1 CohBar, Inc. Profile
Table CohBar, Inc. Overview List
4.4.2 CohBar, Inc. Products & Services
4.4.3 CohBar, Inc. Business Operation Conditions
Table Business Operation of CohBar, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Lixte Biotechnology Holdings, Inc. (Company Profile, Sales Data etc.)
4.5.1 Lixte Biotechnology Holdings, Inc. Profile
Table Lixte Biotechnology Holdings, Inc. Overview List
4.5.2 Lixte Biotechnology Holdings, Inc. Products & Services
4.5.3 Lixte Biotechnology Holdings, Inc. Business Operation Conditions
Table Business Operation of Lixte Biotechnology Holdings, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 NoNO, Inc. (Company Profile, Sales Data etc.)
4.6.1 NoNO, Inc. Profile
Table NoNO, Inc. Overview List
4.6.2 NoNO, Inc. Products & Services
4.6.3 NoNO, Inc. Business Operation Conditions
Table Business Operation of NoNO, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Symic Biomedical, Inc. (Company Profile, Sales Data etc.)
4.7.1 Symic Biomedical, Inc. Profile
Table Symic Biomedical, Inc. Overview List
4.7.2 Symic Biomedical, Inc. Products & Services
4.7.3 Symic Biomedical, Inc. Business Operation Conditions
Table Business Operation of Symic Biomedical, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Taxus Cardium Pharmaceuticals Group Inc. (Company Profile, Sales Data etc.)
4.8.1 Taxus Cardium Pharmaceuticals Group Inc. Profile
Table Taxus Cardium Pharmaceuticals Group Inc. Overview List
4.8.2 Taxus Cardium Pharmaceuticals Group Inc. Products & Services
4.8.3 Taxus Cardium Pharmaceuticals Group Inc. Business Operation Conditions
Table Business Operation of Taxus Cardium Pharmaceuticals Group Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 ViroMed Co., Ltd. (Company Profile, Sales Data etc.)
4.9.1 ViroMed Co., Ltd. Profile
Table ViroMed Co., Ltd. Overview List
4.9.2 ViroMed Co., Ltd. Products & Services
4.9.3 ViroMed Co., Ltd. Business Operation Conditions
Table Business Operation of ViroMed Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Myocardial Ischemia Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Myocardial Ischemia Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Myocardial Ischemia Drugs Sales Revenue Share in 2019, by Company, in USD Million
Table Global Myocardial Ischemia Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Myocardial Ischemia Drugs Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Myocardial Ischemia Drugs Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Myocardial Ischemia Drugs Market Concentration, in 2019
Figure Europe Myocardial Ischemia Drugs Market Market Concentration, in 2019
Figure Asia-Pacific Myocardial Ischemia Drugs MMarket Concentration, in 2019
Figure South America Myocardial Ischemia Drugs Market Concentration, in 2019
Figure Middle East & Africa Myocardial Ischemia Drugs Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Myocardial Ischemia Drugs Demand in Hospital, 2015-2019, in USD Million
Figure Myocardial Ischemia Drugs Demand in Hospital, 2015-2019, in Volume
6.1.2 Demand in Clinic
Figure Myocardial Ischemia Drugs Demand in Clinic, 2015-2019, in USD Million
Figure Myocardial Ischemia Drugs Demand in Clinic, 2015-2019, in Volume
6.1.3 Demand in Others
Figure Myocardial Ischemia Drugs Demand in Others, 2015-2019, in USD Million
Figure Myocardial Ischemia Drugs Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Myocardial Ischemia Drugs Demand Forecast 2020-2025, by Application, in USD Million
Figure Myocardial Ischemia Drugs Market Growth 2020-2025, by Application, in USD Million
Figure Myocardial Ischemia Drugs Market Share in 2025, by Application, in USD Million
Table Myocardial Ischemia Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Myocardial Ischemia Drugs Market Growth 2020-2025, by Application, in Volume
Table Myocardial Ischemia Drugs Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Myocardial Ischemia Drugs Production 2015-2019, by Region, in USD Million
Table Myocardial Ischemia Drugs Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Myocardial Ischemia Drugs Market 2015-2019, by Region, in USD Million
Table Global Myocardial Ischemia Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Myocardial Ischemia Drugs Market 2015-2019, by Region, in Volume
Table Global Myocardial Ischemia Drugs Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in USD Million
Figure North America Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in USD Million
Figure Europe Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in USD Million
Figure South America Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Myocardial Ischemia Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Myocardial Ischemia Drugs Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Tables

List of Table

List of Table

Table Upstream Segment of Myocardial Ischemia Drugs
Table Application Segment of Myocardial Ischemia Drugs
Table Global Myocardial Ischemia Drugs Market 2015-2025, by Application, in USD Million
Table Major Company List of CMK-103
Table Major Company List of DT-010
Table Major Company List of Humanin
Table Major Company List of Others
Table Global Myocardial Ischemia Drugs Market 2015-2019, by Type, in USD Million
Table Global Myocardial Ischemia Drugs Market 2015-2019, by Type, in Volume
Table Global Myocardial Ischemia Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Myocardial Ischemia Drugs Market Forecast 2020-2025, by Type, in Volume
Table Baxalta Incorporated Overview List
Table Business Operation of Baxalta Incorporated (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Overview List
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cellmid Limited Overview List
Table Business Operation of Cellmid Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CohBar, Inc. Overview List
Table Business Operation of CohBar, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lixte Biotechnology Holdings, Inc. Overview List
Table Business Operation of Lixte Biotechnology Holdings, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NoNO, Inc. Overview List
Table Business Operation of NoNO, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Symic Biomedical, Inc. Overview List
Table Business Operation of Symic Biomedical, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Taxus Cardium Pharmaceuticals Group Inc. Overview List
Table Business Operation of Taxus Cardium Pharmaceuticals Group Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ViroMed Co., Ltd. Overview List
Table Business Operation of ViroMed Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Myocardial Ischemia Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Myocardial Ischemia Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Myocardial Ischemia Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Myocardial Ischemia Drugs Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Myocardial Ischemia Drugs Demand Forecast 2020-2025, by Application, in USD Million
Table Myocardial Ischemia Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Myocardial Ischemia Drugs Market Growth 2020-2025, by Application, in Volume
Table Myocardial Ischemia Drugs Market Share in 2025, by Application, in Volume
Table Myocardial Ischemia Drugs Production 2015-2019, by Region, in USD Million
Table Myocardial Ischemia Drugs Production 2015-2019, by Region, in Volume
Table Global Myocardial Ischemia Drugs Market 2015-2019, by Region, in USD Million
Table Global Myocardial Ischemia Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Myocardial Ischemia Drugs Market 2015-2019, by Region, in Volume
Table Global Myocardial Ischemia Drugs Market Share 2015-2019, by Region, in Volume
Table North America Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in Volume
Table Europe Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in Volume
Table South America Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Myocardial Ischemia Drugs Market Size 2015-2019, by Country, in Volume
Table Myocardial Ischemia Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Myocardial Ischemia Drugs Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List

List of Figures

List of Figure

Figure Myocardial Ischemia Drugs Industry Chain Structure
Figure Global Myocardial Ischemia Drugs Market Growth 2015-2019, by Type, in USD Million
Figure Global Myocardial Ischemia Drugs Market Growth 2015-2019, by Type, in Volume
Figure Global Myocardial Ischemia Drugs Sales Revenue Share in 2019, by Company, in USD Million
Figure Global Myocardial Ischemia Drugs Sales Volume Share in 2019, by Company, in Volume
Figure North America Myocardial Ischemia Drugs Market Concentration, in 2019
Figure Europe Myocardial Ischemia Drugs Market Market Concentration, in 2019
Figure Asia-Pacific Myocardial Ischemia Drugs MMarket Concentration, in 2019
Figure South America Myocardial Ischemia Drugs Market Concentration, in 2019
Figure Middle East & Africa Myocardial Ischemia Drugs Market Concentration, in 2019
Figure Myocardial Ischemia Drugs Demand in Hospital, 2015-2019, in USD Million
Figure Myocardial Ischemia Drugs Demand in Hospital, 2015-2019, in Volume
Figure Myocardial Ischemia Drugs Demand in Clinic, 2015-2019, in USD Million
Figure Myocardial Ischemia Drugs Demand in Clinic, 2015-2019, in Volume
Figure Myocardial Ischemia Drugs Demand in Others, 2015-2019, in USD Million
Figure Myocardial Ischemia Drugs Demand in Others, 2015-2019, in Volume
Figure Myocardial Ischemia Drugs Market Growth 2020-2025, by Application, in USD Million
Figure Myocardial Ischemia Drugs Market Share in 2025, by Application, in USD Million
Figure North America Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in USD Million
Figure North America Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in Volume
Figure Europe Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in USD Million
Figure Europe Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in Volume
Figure Asia-Pacific Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in Volume
Figure South America Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in USD Million
Figure South America Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in Volume
Figure Middle East & Africa Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Myocardial Ischemia Drugs Market Size and Growth 2015-2019, in Volume
Figure Marketing Channels Overview

Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...

Global Antibiotic Drugs Market (2024 Edition): Analysis By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others), Spectrum (Broad, Narrow), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoro...

Global Sex Hormone Drugs Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Sex Hormone Drugs Market: The report discusses everything a marketer requires before investing in the global Sex Hormone Drugs Market during the forecast period 2023-2030. It provides detailed...

Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) ...

Executive Summary Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...

Global Microecological Drugs Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Microecological Drugs Market : The report discusses everything a marketer requires before investing in the global Microecological Drugs Market during the forecast period 2023-2030. It provide...

Global Biosynthesis Peptide Drugs Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Biosynthesis Peptide Drugs Market: The report discusses everything a marketer requires before investing in the global Biosynthesis Peptide Drugs Market during the forecast period 2023-2030. It...

Global Chemical Synthesis Peptide Drugs Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Chemical Synthesis Peptide Drugs Market: The report discusses everything a marketer requires before investing in the global Chemical Synthesis Peptide Drugs Market during the forecast period 2...

Global Veterinary Dermatology Drugs Market 2023...

Description The global veterinary dermatology drugs market exhibits positive growth prospects, forecast to expand at a CAGR of 5.4% between 2023 and 2029 to reach USD 8.08 billion in value. Veterinary dermatology focuses on treating skin diseases and disorders in animal patients, covering both...

Global Drug Rehabilitation Drugs Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Drug Rehabilitation Drugs Market : The report discusses everything a marketer requires before investing in the global Drug Rehabilitation Drugs Market during the forecast period 2023-2030. It...

Global Rosuvastatin Drugs Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Rosuvastatin Drugs Market: The report discusses everything a marketer requires before investing in the global Rosuvastatin Drugs Market during the forecast period 2023-2030. It provides detail...